Navigation Links
New Study Provides Benchmarks for Winning Brand Team Management
Date:1/30/2009

CHAPEL HILL, N.C., Jan. 30 /PRNewswire/ -- New research has illustrated the dramatic impact effective structuring of brand teams can have on the success of pharmaceutical product sales before and after launch. In an effort to better understand the best practices in developing effective brand team management, a recent study was conducted by Best Practices, LLC, with insights available in the newly published report, "Winning Brand Team Management: Best Practices in Leadership, Work Practices, Structure and Performance Management." The development of high-performing brand teams in the pharmaceutical industry is a key component in the success of products from phase three into launch and through maturity to maximize opportunities. Benchmark class companies have implemented strategic operational systems to adequately coordinate, communicate and execute the critical activities that support brand growth.

The research explored a number of critical questions, including:

  • Staffing and functional representation for brand team
  • Brand team operations and responsibilities
  • Meeting frequencies
  • Reporting relationships
  • Performance-based compensation and reviews
  • Brand performance measures

Data and executive insights from this study were collected from industry leaders across 26 pharmaceutical and biotech companies including industry pacesetters such as Abbott, Bayer, Genentech, GlaxoSmithKline, Novartis, Roche, Shire, Takeda and Wyeth.

Some of the key findings from the study included:

  • Brand team structure follows a consistent pattern across most pharmaceutical companies, therapeutic areas and drugs.
  • Variations in size and composition of cross-functional teams are usually in response to company-specific conditions.
  • Greater
    '/>"/>

SOURCE Best Practices, LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. New Study Shares Insights for Competitive Intelligence Policies, Ethics and Data Collection
2. New Multi-Center Study Finds Masimo SET Pulse Oximetry Screening Significantly Improves Detection of Congenital Heart Disease in Newborns
3. Epilepsia Study Demonstrates New Add-on Antiepileptic Drug Vimpat(R) (lacosamide) Significantly Reduces Partial-Onset Seizures in Adults With Epilepsy
4. Rib-X Pharmaceuticals Announces Positive Phase 2 Study Results for Delafloxacin and a $25 Million Financing
5. Clinical Research Study Focuses on Little Known Behavioral Changes Related to Parkinsons Disease
6. Cardiovascular Side Effects of Pioglitazone and Rosiglitazone Linked to Vascular and Energy Pathways by Genomas Clinical Study
7. Genomic Health Announces Commencement of QUASAR Clinical Validation Study for Oncotype DX(R) Colon Cancer Assay
8. Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients
9. Aegera Therapeutics Initiates A Randomized Phase 2 Combination Study of AEG35156 for 1st Line Treatment of Non-Small Cell Lung Cancer
10. Star Scientific Announces Successful Completion of Product Satisfaction Study - Results Show Potential for Development and Manufacturing of New Pharmaceutical Product for Smoking and Smokeless Tobacco Cessation
11. Chimerix Completes Phase I Study and Initiates a Phase II Multi-dose Clinical Trial for CMX001
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... Mass. , April 16, 2015  EMD ... Merck KGaA, Darmstadt, Germany , ... Vice President, Head of Global Clinical Development.  Dr. ... expertise, including experience in Oncology and Immunology. She ... ability, having served as a Vice President in ...
(Date:4/16/2015)... and MENLO PARK, Calif. ... (OTCQX: DMPI) (DelMar and the Company), a biopharmaceutical ... in new orphan drug indications, today announced that the ... as a clinical trial site for the ongoing, multicenter ... glioblastoma multiforme (GBM), the most common and deadly form ...
(Date:4/16/2015)... , April 16, 2015  Northwest Biotherapeutics, Inc. ... company developing non-toxic DCVax® personalized immune therapies for ... in the Loncar Cancer Immunotherapy Index (LCINDX), a ... track the immunotherapy field within the biotechnology space.  ... "the top 25 companies" in the immunotherapy space, ...
(Date:4/16/2015)... Modality Solutions, a company that delivers ... industries, is pleased to announce its President, Gary ... Cold Chain IQ - Temperature Control Logistics and ... Global Cold Chain Connections, is dedicated to sharing ... pharmaceutical and healthcare supply chains. , Cold ...
Breaking Biology Technology:Alise Reicin Joins the Biopharmaceutical Business of Merck KGaA, Darmstadt, Germany as Head of Global Clinical Development 2Alise Reicin Joins the Biopharmaceutical Business of Merck KGaA, Darmstadt, Germany as Head of Global Clinical Development 3DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 2DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 3DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 4DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 5NW Bio Included In New Index Of The "Top 25 Cancer Immunotherapy Companies" 2NW Bio Included In New Index Of The "Top 25 Cancer Immunotherapy Companies" 3Modality Solutions Gary Hutchinson Named Columnist for Cold Chain IQ 2Modality Solutions Gary Hutchinson Named Columnist for Cold Chain IQ 3
... Scientific, a leading medical device/biopharmaceutical company located in Santa ... IS CHO-CD XP(TM) Culture System to their cell culture ... a set of chemically-defined*, serum-free, and animal component free ... growth and production for recombinant CHO cell lines. ...
... for BiofuelKINGSTON, ON, March 6 /PRNewswire/ - Performance ... and biofuel biotechnology development and Sustainable Development Technology ... project led by PPI will be receiving up ... will be used to advance its trait technologies ...
... with Major Biopharmaceutical CompanyBELGIUM, Wis., March 6 ... to announce that its subsidiary, Modular Process Constructors ... to better reflect its vision, and announces that ... major global biopharmaceutical and consumer health company. The ...
Cached Biology Technology:Irvine Scientific Launches IS CHO-CD XP(TM) 2Canadian Government Announces Funding for Leading Biotechnology Firm's Project 2Canadian Government Announces Funding for Leading Biotechnology Firm's Project 3Mach One Subsidiary Modular Process Constructors LLC Changes Name to MPS BioPharm to Better Reflect its Vision 2
(Date:3/19/2015)... , March 19, 2015  NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, announces its ... a news clip that aired this week on ... . In a segment "The Next Great Thing", ... ,a new way to pay, and ,a really big breakthrough ...
(Date:3/17/2015)... 2015 Emotient, the leader in facial ... general availability of Emotient Analytics , the ... of facial expressions. The system analyzes videos of ... and services. It delivers audience response metrics - ... as derived from facial evidence of emotional states. ...
(Date:3/12/2015)... Va. , March 12, 2015 IriTech, ... and a member of the Texas Instruments Design Network, ... Naidu has demonstrated its IriShield USB MK2120U device ... scanning facility for pension distribution. The ... assembled to be marketed in India ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 2New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 3New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 4Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 3
... design of vaccines is rapidly expanding their use, safety, and ... of OMICS sciences for global health and vaccine design is ... special issue of OMICS: A Journal of Integrative Biology ... Inc . The issue is available free online . ...
... promiscuous in order to screen out sperm from genetically incompatible ... Anglia (UEA). Published tomorrow in the journal ... of why females in most species mate with multiple males ... and promiscuity can carry fatal risks for the female. ...
... announced that Prof. Madhav Marathe has been selected as ... George A. Michael Distinguished Scholar is an annual award ... time carrying out research at the Institute for Scientific ... intent of the scholarship is to foster long-term collaboration ...
Cached Biology News:21st century vaccines -- innovation in design and rational use 221st century vaccines -- innovation in design and rational use 3Female promiscuity can rescue populations from harmful effects of inbreeding 2Female promiscuity can rescue populations from harmful effects of inbreeding 3
... polypeptide hormones which belong to the ... TGF- superfamily is a large group ... many aspects of development, reproductive function ... incude TGF-s, bone morphogenetic proteins, growth ...
... hormones which belong to the transforming ... superfamily is a large group of ... aspects of development, reproductive function and ... TGF-s, bone morphogenetic proteins, growth differentiation ...
... polypeptide hormones which belong to the ... TGF- superfamily is a large group ... many aspects of development, reproductive function ... incude TGF-s, bone morphogenetic proteins, growth ...
... EZ-Spread Plating Beads Sterile plating ... for glass rods and potentially hazardous ethanol flaming, ... Two choices of ready-to-use sterile packaging: dispenser bottle ... 50 plating, Fastest and easiest way ...
Biology Products: